Connor, Clark & Lunn Investment Management (CC&L)’s Eton Pharmaceutcials ETON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.16M | Sell |
222,083
-10,449
| -4% | -$149K | 0.01% | 715 |
|
|
2025
Q1 | $3.02M | Buy |
232,532
+17,654
| +8% | +$229K | 0.01% | 622 |
|
|
2024
Q4 | $2.86M | Buy |
214,878
+149,864
| +231% | +$2M | 0.01% | 631 |
|
|
2024
Q3 | $390K | Buy |
65,014
+30,167
| +87% | +$181K | ﹤0.01% | 1158 |
|
|
2024
Q2 | $115K | Sell |
34,847
-4,450
| -11% | -$14.6K | ﹤0.01% | 1304 |
|
|
2024
Q1 | $147K | Sell |
39,297
-3,781
| -9% | -$14.2K | ﹤0.01% | 1430 |
|
|
2023
Q4 | $189K | Buy |
43,078
+4,773
| +12% | +$20.9K | ﹤0.01% | 1268 |
|
|
2023
Q3 | $160K | Buy |
+38,305
| New | +$160K | ﹤0.01% | 1256 |
|